This Article Full Text Full Text (PDF) eLetters: Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Broniscer, A. Articles by Gajjar, A. Search for Related Content PubMed PubMed Citation Articles by Broniscer, A. Articles by Gajjar, A.

Supratentorial High-Grade Astrocytoma and Diffuse Brainstem Glioma: Two Challenges for the Pediatric Oncologist

Division of Neuro-Oncology, Department of Hematology-Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA

Correspondence: Alberto Broniscer, M.D., Department of Hematology-Oncology, St. Jude Children’s Research Hospital, 332 North Lauderdale Room C-6066 Mail Stop 260, Memphis, Tennessee 38105, USA. Telephone: 901-495-4925; Fax: 901-521-9005; e-mail: alberto.broniscer{at}stjude.org

Pediatric high-grade gliomas represent a heterogeneous group of tumors that accounts for 15%–20% of all pediatric central nervous system tumors. These neoplasms predominantly involve the supratentorial hemispheres or the pons, in which case the tumors are usually called diffuse brainstem gliomas. The diagnosis of supratentorial neoplasms is dependent on their histologic appearance. The maximum possible surgical resection is always attempted since the degree of surgical resection is the main prognostic factor for these patients. Older children (>3 years) with supratentorial neoplasms undergo a multimodality treatment comprised of surgical resection, radiation therapy, and chemotherapy. The addition of chemotherapy seems to improve the survival of a subset of these children, particularly those with glioblastoma multiforme. However, 2-year survival rates remain poor for children with supratentorial neoplasms, ranging from 10%–30%.

The diagnosis of a diffuse brainstem glioma is based upon typical imaging, dispensing with the need for surgery in the majority of cases. Radiation therapy is the mainstay of treatment for children with diffuse brainstem gliomas. The role of chemotherapy for these children is not clear, and it is, in general, employed in the context of an investigational study. Less than 10% of children with diffuse brainstem gliomas survive 2 years.

Because the outcome for patients with either type of tumor is poor when standard multimodality therapy is used, these children are ideal candidates for innovative treatment approaches.

Key Words. Children • Gliomas • Astrocytomas • High-grade • Brainstem

This article has been cited by other articles:

				J. Fangusaro Pediatric High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas J Child Neurol, November 1, 2009; 24(11): 1409 - 1417. [Abstract] [PDF]

				J. N Johnson, R. K Dhillon, and J. L Anderson Acute vomiting and mental status changes: a case of acute intraventricular haemorrhage from an optic chiasm tumour BMJ Case Reports, June 1, 2009; 2009(jun01_1): bcr1220081410 - bcr1220081410. [Abstract] [Full Text]

				I. Qaddoumi, N. Ezam, M. Swaidan, I. Jaradat, A. Mansour, N. Abuirmeileh, E. Bouffet, and M. Al-Hussaini Diffuse Pontine Glioma in Jordan and Impact of Up-front Prognosis Disclosure With Parents and Families J Child Neurol, April 1, 2009; 24(4): 460 - 465. [Abstract] [PDF]

				A. Broniscer, S. J. Baker, C. F. Stewart, T. E. Merchant, F. H. Laningham, P. Schaiquevich, M. Kocak, E. B. Morris, R. Endersby, D. W. Ellison, et al. Phase I and Pharmacokinetic Studies of Erlotinib Administered Concurrently with Radiotherapy for Children, Adolescents, and Young Adults with High-Grade Glioma Clin. Cancer Res., January 15, 2009; 15(2): 701 - 707. [Abstract] [Full Text] [PDF]

				N. G. Gottardo and A. Gajjar Chemotherapy for Malignant Brain Tumors of Childhood J Child Neurol, October 1, 2008; 23(10): 1149 - 1159. [Abstract] [PDF]

				H. K. Thorarinsdottir, M. Santi, R. McCarter, E. J. Rushing, R. Cornelison, A. Jales, and T. J. MacDonald Protein Expression of Platelet-Derived Growth Factor Receptor Correlates with Malignant Histology and PTEN with Survival in Childhood Gliomas Clin. Cancer Res., June 1, 2008; 14(11): 3386 - 3394. [Abstract] [Full Text] [PDF]

				D. S. Ziegler, A. L. Kung, and M. W. Kieran Anti-Apoptosis Mechanisms in Malignant Gliomas J. Clin. Oncol., January 20, 2008; 26(3): 493 - 500. [Abstract] [Full Text] [PDF]

				A. Broniscer, S. J. Baker, A. N. West, M. M. Fraser, E. Proko, M. Kocak, J. Dalton, G. P. Zambetti, D. W. Ellison, L. E. Kun, et al. Clinical and Molecular Characteristics of Malignant Transformation of Low-Grade Glioma in Children J. Clin. Oncol., February 20, 2007; 25(6): 682 - 689. [Abstract] [Full Text] [PDF]

				E. W. Newcomb, S. Demaria, Y. Lukyanov, Y. Shao, T. Schnee, N. Kawashima, L. Lan, J. K. Dewyngaert, D. Zagzag, W. H. McBride, et al. The Combination of Ionizing Radiation and Peripheral Vaccination Produces Long-term Survival of Mice Bearing Established Invasive GL261 Gliomas Clin. Cancer Res., August 1, 2006; 12(15): 4730 - 4737. [Abstract] [Full Text] [PDF]

				R. K. Rosenblum Brain Stem Glioma: Two Case Studies Journal of Pediatric Oncology Nursing, March 1, 2005; 22(2): 114 - 118. [Abstract] [PDF]